https://es.marketscreener.com/cotizacion/accion/ALTERITY-THERAPEUTICS-LIM-57291688/noticia/El-Comite-de-Supervisi-n-de-Datos-de-Fase-2-de-Alterity-Therapeutics-recomienda-continuar-el-ensay-45892999/?utm_source=telegram&utm_medium=social&utm_campaign=share